Ş. Şentürk Et Al. , "Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders," ACS OMEGA , vol.8, no.48, pp.46101-46112, 2023
Şentürk, Ş. Et Al. 2023. Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders. ACS OMEGA , vol.8, no.48 , 46101-46112.
Şentürk, Ş., Akbaba, H., Erel Akbaba, G., & Başpınar, Y., (2023). Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders. ACS OMEGA , vol.8, no.48, 46101-46112.
Şentürk, ŞERİF Et Al. "Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders," ACS OMEGA , vol.8, no.48, 46101-46112, 2023
Şentürk, ŞERİF Et Al. "Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders." ACS OMEGA , vol.8, no.48, pp.46101-46112, 2023
Şentürk, Ş. Et Al. (2023) . "Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders." ACS OMEGA , vol.8, no.48, pp.46101-46112.
@article{article, author={ŞERİF ŞENTÜRK Et Al. }, title={Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders}, journal={ACS OMEGA}, year=2023, pages={46101-46112} }